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Abstract
Background: Teneurins are a unique family of transmembrane proteins conserved from C. elegans
and D. melanogaster to mammals. In vertebrates there are four paralogs (teneurin-1 to -4), all of
which are expressed prominently in the developing central nervous system.
Results: Analysis of teneurin-1 expression in the developing chick brain by in situ hybridization and
immunohistochemistry defined a unique, distinct expression pattern in interconnected regions of
the brain. Moreover we found complementary patterns of teneurin-1 and-2 expression in many
parts of the brain, including the retina, optic tectum, olfactory bulb, and cerebellum as well as in
brain nuclei involved in processing of sensory information. Based on these expression patterns, we
suspect a role for teneurins in neuronal connectivity.
In contrast to the cell-surface staining of the antibody against the extracellular domain, an antibody
recognizing the intracellular domain revealed nuclear staining in subpopulations of neurons and in
undifferentiated mesenchyme. Western blot analysis of brain lysates showed the presence of N-
terminal fragments of teneurin-1 containing the intracellular domain indicating that proteolytic
processing occurs. Finally, the teneurin-1 intracellular domain was found to contain a nuclear
localization signal, which is required for nuclear localization in transfected cells.
Conclusion: Teneurin-1 and -2 are expressed by distinct interconnected populations of neurons
in the developing central nervous system. Our data support the hypothesis that teneurins can be
proteolytically processed leading to the release of the intracellular domain and its translocation to
the nucleus.
Background
Teneurins are a family of type II transmembrane proteins
originally discovered as pair-rule gene products in Dro-
sophila [1,2] and [3]. Homologs have been identified in
chicken, mouse and humans called teneurin-1 to -4 (for
reviews see [4] and [5]).
Teneurin domain architecture is highly conserved across
phyla. All teneurins described to date have an extracellular
Published: 25 March 2008
BMC Developmental Biology 2008, 8:30 doi:10.1186/1471-213X-8-30
Received: 30 August 2007
Accepted: 25 March 2008
This article is available from: http://www.biomedcentral.com/1471-213X/8/30
© 2008 Kenzelmann et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
Page 2 of 14
(page number not for citation purposes)
domain (ECD) with eight tenascin-type EGF-like repeats
followed by a region of conserved cysteines and YD-
repeats [6]. The N-terminal intracellular domain (ICD) of
vertebrate teneurins has a conserved and unique domain
architecture, containing two polyproline motifs, EF-hand-
like metal ion binding domains and several putative
phosphorylation sites.
The expression of vertebrate teneurins has been studied
most extensively in mouse and chicken. All of these
reports are in agreement that the primary site of teneurin
expression is the developing central nervous system ([7-
13]), although teneurins are also expressed outside the
nervous system at sites of pattern formation like the limb
bud [14,15]. The expression of teneurins in specific sub-
sets of neurons is conserved from Drosophila and C. elegans
to vertebrates. For example, in the chicken visual system
teneurin-1 transcripts are concentrated in the neurons of
the tectofugal pathway, whereas mRNA encoding ten-
eurin-2 is concentrated in the neurons of the thalamofu-
gal pathway [16]. The pattern and timing of expression led
to speculation that teneurins might have a role in synaptic
connectivity. Further evidence for such a function is pro-
vided by the observation that teneurin-1 and -2 promote
neurite outgrowth in vitro [7,8], (see also [17]) and in
vivo [18], and by the fact that teneurins can homo- and
heterodimerize through their EGF-like repeats [19].
Recently, the teneurin-4 gene was found in a screen for
genes differentially regulated in emx-/- mice, and because
of its intriguing expression pattern, in situ hybridization
was performed for all four teneurin paralogs revealing gra-
dients of expression and striking complementary expres-
sion in the mouse forebrain [13]. Interestingly, the
human teneurin-1 gene is located on the X-chromosome
in a region to which several X-linked mental retardation
(XLMR) syndromes have been mapped [7]. The predomi-
nant neuronal expression and suggested function in brain
development make teneurin-1 a promising candidate
gene for XLMR.
The discovery of teneurins in Drosophila as the only pair-
rule gene that is not a transcription factor suggested that
teneurins – although transmembrane proteins – could
also have a nuclear function [3]. Transfection of a full-
length teneurin-2 reporter construct with a transcriptional
activator attached to its N-terminus resulted in transcrip-
tion of a reporter gene particularly in response to homo-
typic interactions, indicating that the ICD is released upon
specific stimuli [20]. In vitro the teneurin-2 ICD localizes
to PML-bodies in the nucleus and affects zic-1 mediated
transcription [20]. Similarly, the teneurin-1 ICD colocal-
izes in the nucleus with MBD1, a methyl CpG binding
protein, after co-tranfection of cells in culture [21]. West-
ern blot analysis of cells transfected with full-length ten-
eurin-1 show several N-terminal peptides which could
correspond to intermediate processing products and the
ICD, but it was not possible to visualize the ICD in the
nucleus by immunofluorescence [21]. Assuming that the
released intracellular domain has an important signalling
function, it is likely that such a cleavage is tightly regulated
during development and that it would not occur sponta-
neously in cell culture, or only to a very small extent.
The aim of this work was to analyze teneurin-1 expression
in detail and to determine if teneurins can be processed in
the vertebrate embryo as they appear to be processed in
vitro. We have studied the expression pattern and process-
ing of teneurin-1 in the developing chicken embryo using
in situ hybridization, immunhistochemistry and immu-
noblotting, and have compared the patterns of teneurin-1
expression with those of teneurin-2. As antisera to ten-
eurin-1 were raised against both the ICD and ECD of the
protein, we were able to show for the first time the nuclear
localization of the ICD in neurons and mesenchymal tis-
sues in situ. The processing of teneurin-1 in developing
tissues was confirmed by immunoblot analysis. Finally,
we show that the teneurin-1 ICD contains a specific
nuclear localization signal that is required for transloca-
tion into the nucleus.
Results
In situ localization of teneurin-1 transcripts
Teneurin-1 was widely expressed in the chick nervous sys-
tem at embryonic day (E) 17. The strongest hybridization
signals seen with the teneurin-1 antisense probe were in
the mitral cells of the olfactory bulb (Fig. 1A), subpopula-
tions of neurons in the hippocampus and piriform cortex
(not shown, but see immunohistochemistry), retinal gan-
glion cells and cells found in the inner nuclear layer adja-
cent to the inner plexiform layer (Fig. 1B), the large
neurons found within the rotund nucleus (Fig. 1C), and
the neurons of the stratum griseum centrale of the optic
tectum (Fig. 1D). In the hindbrain teneurin-1 mRNAs
were found in the nucleus laminaris and nucleus magno-
cellularis (Fig. 1E) and throughout the cerebellum (Fig.
1F). Adjacent sections processed with a sense probe were
unlabelled. Thus, the expression of teneurin-1 in the
chicken embryo is more widespread than suggested by our
earlier studies using a less sensitive radiolabeled probe
that only detected the most abundant sites of expression
in the visual system. In addition to the strong expression
in interconnected subset of neurons in the tectofugal por-
tions of the visual system (e.g., retinal ganglion cells, the
stratum griseum centrale of the optic tectum and the
rotund nucleus), teneurin-1 transcripts were also present
in diverse brain regions involved in general sensation,
olfaction, the processing of auditory information, and the
coordination of complex motor behavior.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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Immunolocalization of teneurin-1 and teneurin-2
Polyclonal antibodies raised against recombinant frag-
ments of teneurin-1 were used to study the distribution of
teneurin-1 protein in the developing avian nervous sys-
tem. Our results are summarized in Figure 2 and are
briefly described here starting in the rostral forebrain and
ending in the hindbrain, emphasizing regions also illus-
trated in Figure 1. At E17 the anti-teneurin-1 serum
labelled the glomerular layer and mitral cell layer of the
olfactory bulb (Fig. 2A). This pattern is consistent with the
expression of teneurin-1 by mitral cells shown in Figure
1A and the transportation of the protein to the dendrites
of mitral cells in the glomerular layer. In the retina ten-
eurin-1 immunolabelling was observed in retinal gan-
glion cells, neurons within the inner nuclear layer
adjacent to the inner plexiform layer, and within distinc-
tive laminae (especially 2 and 5) within the inner plexi-
form layer (Fig. 2C). As predicted by in situ hybridization,
teneurin-1 immunoreactivity was particularly strong
throughout the rotund nucleus (Fig. 2E) and in the large
neurons of the stratum griseum centrale of the optic tec-
tum (Fig. 2G), two interconnected populations of neu-
rons that make up part of the tectofugal visual pathway.
Finally, the anti-teneurin-1 labelled the dendritic field of
the external portion of the nucleus laminaris (Fig. 2I), the
large neurons of the nucleus magnocellularis (Fig. 2I),
and in the cerebellum labelled Purkinje cells and the por-
tion of the molecular layer adjacent to the external granu-
lar layer (Fig. 2K). Note that the teneurin-1 expression
pattern observed with the antibody is more extensive in
most brain regions than observed by in situ hybridization.
For example, neurons in the outer portion of the inner
nuclear layer of the E17 retina are stained with the anti-
body (Fig. 2C), but are not positive for teneurin-1 tran-
scripts (Fig. 1B). Since these cells were not stained with
preimmune serum or secondary antibody only controls
(not shown), a possible explanation for this discrepancy
is that teneurin-1 transcripts are present below the level of
detection of our in situ hybridization protocol in some
regions, but nevertheless at levels sufficient to generate
enough protein to be recognized, albeit faintly, by immu-
nohistochemistry.
In situ hybridization has previously suggested that the
patterns of expression of teneurin-1 and teneurin-2 are
largely complimentary with the possible exception of the
retina, where transcripts encoding these proteins
appeared to co-localize in retinal ganglion cells and in
Teneurin-1 is expressed in many parts of the developing CNS Figure 1
Teneurin-1 is expressed in many parts of the developing CNS. In situ hybridization at E17 with a teneurin-1 antisense 
probe (sense controls were negative). In the olfactory bulb (A), there is a strong hybridization signal in the mitral cell layer 
(mcl). The ganglion cell layer (gcl) is also positive, but the external plexiform layer (epl) is not. In the retina (B), the ganglion cell 
layer (gcl) is labelled intensely, and there is a faint signal in neurons of the inner nuclear layer (inl) adjacent to the inner plexi-
form layer (ipl). The pigment retina (pr) has dark melanosomes. The nucleus rotundus (C) contains large, scattered neurons 
that are positive for teneurin-1 mRNA. In the optic tectum (D) teneurin-1 mRNA is widespread, but is seen most clearly in the 
large neurons of the stratum griseum centrale (sgc). In the hindbrain (E) the nucleus laminaris (La) and nucleus magnocellularis 
(MCC) are labelled, as are Purkinje cells (Pcl) and other neurons in the cerebellum (F).BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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cells near the developing inner plexiform layer, which
may be amacrine cells. Here we were able to compare the
distribution of teneurin-1 and teneurin-2 by superimpos-
ing the patterns of expression found on adjacent frozen
sections stained with antisera specific for each protein. In
each region examined, there was very little overlap in the
expression of the two proteins. For example, in the olfac-
tory bulb teneurin-2 immunoreactivity was seen in the
external plexiform layer sandwiched between the layers of
teneurin-1 expression (Fig. 2B). In the retina both ten-
eurin-1 and teneurin-2 were found in the inner plexiform
layer, but they are concentrated in different laminae: ten-
eurin-1 is found primarily in laminae 2 and 5, while ten-
eurin-2 is most prominently expressed in laminae 1 and 3
(Fig. 2D). In the thalamus teneurin-2 immunoreactivity
was seen in the pretectal region and was completely
excluded from the adjacent rotund nucleus (Fig. 2F). In
the optic tectum anti-teneurin-2 immunolabelled puncta
surrounding the large neurons of the stratum griseum cen-
trale, but did not label the neuronal cell bodies them-
selves (Fig. 2H). The complementary expression of the
two teneurins was particularly evident in the nucleus lam-
inaris, where teneurin-2 immunoreactivity was seen in the
thick dendritic field of the internal portion of the lamina
and teneurin-1 was found in the thinner external portion
(Fig. 2J). Finally, while teneurin-1 and teneurin-2 are both
found in the molecular layer of the developing cerebel-
lum, teneurin-1 was found in the younger, external por-
tion of this layer whereas teneurin-2 was found in the
more mature, internal portion (Fig. 2L). A summary of
Teneurin-1 is expressed in interconnected regions of the brain and is complementary to teneurin-2 expression Figure 2
Teneurin-1 is expressed in interconnected regions of the brain and is complementary to teneurin-2 expression. 
Immunostaining of teneurin-1 and teneurin-2 in E17 brain. Green, teneurin-1; red, teneurin-2, blue (Hoechst), nuclei. In the 
olfactory bulb (A, B) the teneurin-1 antibody labels the mitral cell layer (mcl) and the glomerular layer. The external plexiform 
layer (epl) is positive for teneurin-2. In the temporal retina (C, D) subsets of neurons within the ganglion cell layer (gcl) and 
inner portion of the internal nuclear layer (inl) are positive for teneurin-1, as are laminae 2 and 5 within the inner plexiform 
layer (ipl). Teneurin-2 immunoreactivity is concentrated in laminae 1 and 3 of the ipl. The nucleus rotundus (E, ROT) is 
intensely labelled with teneurin-1 antibody, but not with anti-teneurin-2 (F). In the optic tectum (G, H) large neurons in the 
stratum griseum centrale (SGC) are positive for teneurin-1, but not teneurin-2. In the hindbrain (I, J), the nucleus laminaris (La) 
and nucleus magnocellularis (MCC) are labelled with the teneurin-1 antibody. Teneurin-1 and teneurin-2 immunoreactivity are 
found in distinctive dendritic fields within the La. In the cerebellum (K, L) teneurin-1 is found in Purkinje cells (Pcl) and in the 
molecular layer (ml) adjacent to the external granular layer (egl). In contrast, the anti-teneurin-2 labels the internal portion of 
the ml.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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teneurin-1 and -2 expression in the developing chick
brain is provided in Table 1.
Nuclear localization of the intracellular domain in situ
Antibodies detecting the ICD (anti-ICD) or the ECD (anti-
EGF and anti-ECD, see Fig. 3A) of teneurin-1 were used to
detect teneurin-1 expression in brain homogenates har-
vested from chicken embryos.
The ICD antibody was used to determine if the ICD of ten-
eurin-1 can be detected in the nucleus in situ with immu-
nohistochemistry. We found nuclear teneurin-1 ICD in a
few regions of the developing brain. One region where the
majority of neurons expressing teneurin-1 showed
nuclear localization with the anti-ICD was the E17 piri-
form cortex (Fig. 3B, C). Here the anti-ICD stained fine
puncta within nuclei as determined by co-staining with
the Hoechst nuclear stain. The same fine puncta were
labelled in the nuclei of neurons within the retinal gan-
glion cell layer at E12 (Fig. 3D, E). However, unlike the
labelling of the piriform cortex the labelling pattern
within the retinal ganglion cell layer was diverse: the
nuclei of some cells are labelled (arrow, Fig. 3E), in some
cells only the cytoplasm or cell membrane was labelled
(arrowhead, Fig. 3E), and other cells were completely
unlabelled (asterisks, Fig. 3E). All of these cells were iden-
tified as neurons by double labelling with the neuronal
marker TuJ1 (not shown). The appearance of the ICD of
teneurin-1 in the nuclei of retinal neurons is temporally
and spatially regulated, as nuclear localization in the reti-
nal ganglion cell layer was not observed at E7 or E17 (not
shown), nor was it observed in neurons in the inner
nuclear layer at any of the time points used in this study.
The most dramatic examples of nuclear localization of the
ICD of teneurin-1 were seen in non-neuronal tissues. In
patches of head mesenchyme of E7 and E12 embryos the
anti-ICD labelled the nuclei of fibroblasts intensely (Fig.
3H, I), in contrast to the antibody raised against the EGF-
like repeats found in the ECD (Fig. 3F, G). The nuclear
staining was specific, as it was abolished by preabsorbing
the antibody with the ICD-peptide (not shown). Note
that these two antibodies (anti-ICD and anti-EGF) stained
the same regions of the fore, mid and hindbrain identi-
cally except for the occasional staining of some cell nuclei
by the former and not the latter. Also, the anti-ICD stained
some endothelial cells and the anti-EGF did not (e.g., note
the endothelial cell labelling in Fig. 2I, which was stained
with anti-ICD).
Teneurin-1 appears to be proteolytically processed
Western blot analysis using the ICD antibody showed a
prominent band at 65 kDa (Fig. 4A, arrowhead), which is
much smaller than expected for the full length protein (>
300 kDa). The specificity was confirmed by competition
with the ICD peptide which completely abrogates detec-
tion of this band (not shown). However, 65 kDa is larger
than we would expect for the teneurin-1 ICD, because an
N-terminal fragment containing the amino acids up to the
transmembrane domain (ICD construct) migrates at 45
kDa [21]. Therefore, this fragment may still contain the
transmembrane domain. Such an N-terminal fragment
would be expected to occur after ectodomain shedding
(Fig. 4C, cleavage 1). The full-length protein was barely
detectable (Fig. 4A, arrow), indicating that ectodomain
shedding may take place constitutively. The faint bands
observed below the 65 kDa band (Fig. 4A, asterisks) at
approximately 50 and 35 kDa might be the released ICD
generated after the second cleavage (Fig. 4C, cleavage 2),
which occurs only in a specific subset of cells. These data
Table 1: The expression of teneurin-1 and teneurin-2 in the E17 
avian central nervous system
Region Teneurin-1 
Intensity*
Teneurin-2 
Intensity
Olfactory bulb: Glomerular layer ++ -
Olfactory bulb: External plexiform layer - +
Hippocampus +/- +++
Hyperstriatrum accessorium - ++
Hyperstriatum ventrale - ++
Nucleus septalis lateralis - ++
Nucleus taeniae - ++
Posteromedial cortex piriformis +/- +++
Nucleus dorsolateral anterior thalami - ++
Nucleus geniculatus lateralis - ++
Nucleus pretectalis - ++
Nucleus rotundus +++ -
Nucleus spiriformis - ++
Nucleus triangularis - ++
Retina: Ganglion cell layer +/- -
Retina: Inner plexiform layer 5 + -
Retina: Inner plexiform layer 4 - +/-
Retina: Inner plexiform layer 3 - ++
Retina: Inner plexiform layer 2 + -
Retina: Inner plexiform layer 1 - +
Retina: Inner nuclear layer +/- -
Retina: Outer plexiform layer - +/-
Nucleus isthmi, pars magnocellularis - ++
Nucleus isthmi, pars parvocellularis - ++
Nucleus isthmo-opticus - ++
Nucleus lentiformis mesencephali - ++
Nucleus of Edinger-Westphal - ++
Stratum griseum centrale ++ -
Stratum griseum et fibrosum 
superficiale
+/- +
Stratum griseum periventriculare - +
Nucleus laminaris ++ +/-
Nucleus magnocellularis ++ -
Cerebellum: Molecular layer +/- +/-
Cerebellum: Purkinje cell layer + -
Cerebellum: Granule cell layer - +/-
*+++, intense signal, visible at low magnification; ++, strong signal, 
visible at intermediate magnification; +, weak signal, visible at high 
magnification; +/-, weak and sometimes missing; -, no signalBMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
Page 6 of 14
(page number not for citation purposes)
Nuclear teneurin-1 intracellular domain is observed in subsets of neurons and in specific tissues Figure 3
Nuclear teneurin-1 intracellular domain is observed in subsets of neurons and in specific tissues. Schematic dia-
gram of teneurin domain architecture and antibodies used in this study (A). Comparison of immunostaining with antibodies to 
the extracellular and intracellular domains in sections and in vitro (B to I). Neurons of the piriform cortex at E17 (B, C) and 
neurons found in the retinal ganglion cell layer at E12 (D, E) stained with anti-ICD. The anti-ICD labels nuclei in the piriform 
cortex and labels a subset of retinal ganglion cells (arrow), but other TuJ1-positive neurons (label not shown) in the retinal gan-
glion cell layer are labeled with anti-ICD teneurin-1 but do not exhibit nuclear staining (arrowhead). There are also TuJ1-posi-
tive neurons in the retinal ganglion cell layer that are negative for teneurin-1 (asterisk). Head mesenchyme at E7 stained with 
anti-EGF (F, G) and anti-ICD (H, I). In the head mesenchyme, the anti-ICD labels the nucleus of most cells, whereas the anti-
EGF exhibits cell-surface staining. Green, teneurin-1; blue (Hoechst), nuclei.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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Teneurin-1 appears to be processed in the developing chicken brain Figure 4
Teneurin-1 appears to be processed in the developing chicken brain. Western blot analysis of embryonic chicken 
brain lysates. Detection of endogenous teneurin-1 using anti-ICD (A) and anti-ECD antibodies (B). The numbers to the left 
indicate the positions of molecular weight standards. The anti-ICD detects a prominent N-terminal fragment at 65 kDa (arrow-
head), which is much smaller than expected for the full-length protein (arrow), suggesting proteolytic processing. In contrast, 
using the anti-ECD antibody results in detection of the full-length protein (arrow) and a large C-terminal fragment (arrow-
head). Asterisks label additional processing products (see text for details). Postulated cleavage sites and calculated molecular 
weights of processing products (C). Postulated cleavage sites: 1 = ectodomain shedding, 2 = intramembrane cleavage releasing 
the ICD. The sizes indicated are predicted from the amino acid sequence; known apparent molecular weights are shown in 
parentheses (see text for details). The calculated molecular weights are approximate, as the exact cleavage sites are not 
known.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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suggest that proteolytic processing of the full-length pro-
tein takes place in vivo, resulting in N-terminal fragments.
When the same extracts were analyzed using an antibody
detecting the ECD (Fig. 4B), a faint band > 250 kDa
(arrow) and a stronger band around 250 kDa (arrow-
head) are observed. Since the predicted molecular weight
of full-length teneurins is more than 300 kDa, the upper
band may represent the full-length protein, and the lower
band could correspond to the ECD after shedding, which
has a predicted molecular weight of 245 kDa (Fig. 4C).
The smear above these bands can be explained by glyco-
sylation of the extracellular part of the protein [7]. The
band at 150 kDa (Fig. 4B, asterisk) could be a further
cleaved extracellular fragment of teneurin-1. In Figure 4C
the postulated cleavage sites and the resulting fragments
are summarized. Note that the molecular weights are
either calculated based on the amino sequences or based
on observations (shown in parentheses). The ICD has a
higher apparent molecular weight than predicted, there-
fore we expect the same to be the case for the 65 kDa N-
terminal fragment, for which the predicted molecular
weight would only be 56 kDa (Fig. 4C).
Identification of a nuclear localization signal
The ICD of teneurin-1 contains the amino acid sequence
arginine-lysine-arginine-lysine at position 62 to 65 from
the N-terminus. This resembles a classical nuclear locali-
zation signal (NLS), which directs the nuclear import of
proteins. This putative NLS is conserved in chicken,
mouse and human teneurin-1. To test whether it is func-
tional, the four basic amino acids were replaced by
alanines in the construct named NLS-mut (Fig. 5A). COS-
7 cells were transfected either with a construct encoding
the ICD of teneurin-1 (ICD-wt) or the NLS-mut construct.
Western blot analysis of cytoplasmic and nuclear extracts
of the transfected cells showed decreased nuclear accumu-
lation of the NLS-mut construct compared to the ICD-wt
construct (Fig. 5B). Quantification of the nuclear-to-cyto-
plasmic ratio showed that ICD-wt accumulates in the
nucleus, which is not the case for NLS-mut (Fig. 5C). The
ICD-wt protein is detected in the nucleus by immunoflu-
orescence (Fig. 5D, E). However, nuclear localization of
the ICD was abolished if the NLS is mutated (Fig. 5F, G).
More than 80% of the cells expressing the wt-construct
exhibited nuclear staining, whereas this was only
observed in 20% of the cells expressing the NLS-mut ver-
sion (Fig. 5H). In addition to the strongly decreased
nuclear localization, these cells also exhibited a more pro-
nounced localization of the teneurin-1 ICD to the cell
membrane and cell processes.
Discussion
In this work we analyzed the expression of teneurin-1 in
the chicken embryo by in situ hybridization and immu-
nohistochemistry, focusing on the developing nervous
system. Using an antibody recognizing the N-terminus of
teneurin-1 we demonstrated for the first time the nuclear
localization of a teneurin ICD in a developing vertebrate.
This finding was supported by western-blot analysis of
endogenous teneurin-1 and can be explained by the fact
that the ICD contains a functional NLS. Thus, teneurin-1
is a transmembrane protein that can be processed to
deliver a signal to the nucleus with the potential to alter
gene expression.
Teneurin-1 expression suggests a role in the establishment 
of neuronal connectivity
Teneurin-1 has a distinctive temporal-spatial expression
pattern in the developing nervous system that includes
interconnected regions in the brain. For example, in the
tectofugal pathway of the avian visual system, retinal gan-
glion cells project to neurons in the stratum griseum cen-
trale of the optic tectum, which in turn, project to the
nucleus rotundus. Teneurin-1 is expressed prominently by
each component of this pathway. However, teneurin-1
expression is not limited to the visual system, but is also
present in other parts of the brain. In the olfactory path-
way, teneurin-1 is expressed both in the olfactory bulb
and the piriform cortex, which receives input from mitral/
tufted cells of the olfactory bulb and is involved in
processing of odor information. Teneurin-1 mRNA and
immunostaining were also present in nuclei processing
auditory information such as the nucleus laminaris and
the nucleus magnocellularis. In previous studies of ten-
eurin-1 expression, which relied on low resolution in situ
hybridization techniques, the expression of teneurin-1
outside the avian visual system was not observed [7,8].
The broader expression reported here is in line with stud-
ies in mice, where teneurin-1 has been reported to be
expressed in specific parts of the cortex [13] as well as the
hippocampus and cerebellum [22,12]. In both mouse and
chicken, a common feature is the expression of teneurin-
1 by interconnected neurons (see review [5]).
One of the most interesting features of teneurins is the
complementarity of their expression patterns. A previous
study [16] reported the presence of teneurin-2 in the tha-
lamofugal visual pathway; here we confirmed the expres-
sion of teneurin-1 in the tectofugal visual pathway. This
complementarity is again not limited to the visual system,
but appears also in the olfactory bulb and in the nucleus
laminaris and nucleus magnocellularis. The most intrigu-
ing complementary pattern was found in the inner plexi-
form layer in the retina, which is subdivided in five
laminae. There, axons of the amacrine and bipolar cells
meet the dendrites of retinal ganglion cells. Because most
of these nerve terminals are confined to distinct laminae,
it is thought that lamination is a major determinant of
synaptic specificity in the retina. Teneurin-1 and teneurin-
2 were found in distinct, non-overlapping laminae, sug-BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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The teneurin-1 intracellular domain contains a nuclear localization signal Figure 5
The teneurin-1 intracellular domain contains a nuclear localization signal. The amino acid sequence representing a 
putative nuclear localization signal (NLS) which was mutagenized to alanines (A). Western blot analysis of total lysates, cyto-
plasmic and nuclear fractions of COS-7 cells mock transfected, transfected with wild type ICD (ICD-WT) or transfected with 
the mutated NLS (NLS-Mut) constructs (B). Blots were probed with the anti-ICD, an antibody to the cytoplasmic protein vin-
culin, or an antibody to the nuclear protein Oct-1. Western blot quantification and calculation of the nuclear-to-cytoplasmic 
ICD ratio (C). Immunofluorescence staining of transfected COS-7 cells (D-G) and quantification of nuclear localization by cell 
counting (H). Both western blot analysis and immunofluorescence show that the overexpressed wild-type ICD is localized in 
the nucleus, whereas the NLS-Mut construct is predominantly found in the cytoplasm.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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gesting that they are expressed by distinctive subpopula-
tions of neurons. Other examples of molecules present in
distinct sublaminae of the retina were reported by
Yamagata et al., including the adhesive proteins sidekick-
1 and -2 [23]. Retinal ganglion cells expressing sidekick-1
or -2 preferentially arborize in sidekick-1 or-2 positive
sublaminae, and ectopic expression of each sidekick
directs dendrites to sublaminae where the corresponding
sidekick is present [24]. These observations suggest roles
for each of the teneurins in the development of different
neuronal pathways. The current study also provides evi-
dence that a given neuron may switch teneurin expression
as development proceeds. In the cerebellum, for example,
teneurin-1 immunoreactivity is seen in the axons of gran-
ule cells adjacent to the external granular layer, whereas
teneurin-2 immunoreactivity is seen in the axons of the
older granule cells near the perikarya of Purkinje cells.
Based on its expression pattern we suggest a role for ten-
eurins in the establishment of appropriate connectivity in
the developing brain. This task is preformed in several
steps, including the generation of appropriate neuronal
cell types, migration of neurons to specific nuclei or lam-
inae, growth of axons to target areas, and the formation
and maintenance of synapses within the target [25-27].
Recent evidence suggests that the same molecules can be
involved in several of these steps [28]. Currently there is
no knowledge about a possible role of teneurins in defin-
ing neuronal precursor subpopulations, but there are
some data indicating that teneurins are involved in the
outgrowth and migration of axons. For example, teneur-
ins promote neurite outgrowth in vitro, and recently pub-
lished in vivo data show that the cell bodies of neurons
expressing teneurin-3 (tenm_3) tend to cluster, their proc-
esses are intertwined, and have increased neurite out-
growth [18].
In 1963, Roger Sperry formulated his chemoaffinity
hypothesis, according to which growing axons carry bio-
chemical "tags" which allow them to find their appropri-
ate target region [29]. In the meantime, many molecules
that act in such a manner have been discovered; the best
known example is the cadherin superfamily. Cadherins
not only act as cell adhesion molecules through
homophilic interactions mediated by their ECD, but are
also involved in signal transduction through their ICDs.
Many cadherins are also expressed in very restricted
regions in the brain indicating a role in establishment of
neuronal connections [30,31]. The observation that ten-
eurins can mediate homophilic and heterophilic interac-
tions suggests that they might function in a similar way to
cadherins [19].
Regarding the complexity of the vertebrate brain, it is
unlikely that only a few molecules govern compartmen-
talization and wiring in the developing brain. More prob-
ably, concerted action of many different genes is required,
and it will be a challenge to define the exact role of teneur-
ins within this genetic network. To date, very little is
known about the factors which regulate teneurin expres-
sion and how the teneurins function. For further analysis
of the role of teneurins in brain development, it will be
crucial to manipulate the expression or function of ten-
eurins in vivo.
Teneurins appear to be processed in vivo, possibly by 
regulated intramembrane proteolysis
At specific sites we observed nuclear staining with the anti-
body to the ICD of teneurin-1. These sites, both neuronal
and non-neuronal, were subsets of the regions where ten-
eurin-1 was expressed. This was confirmed with in situ
hybridization and with antibodies to the ECD of teneurin-
1. Western blot analysis confirmed the presence of N-ter-
minal fragments of teneurin-1. Additionally, the ICD was
found to contain a conserved NLS, which we demon-
strated was functional in cultured cells.
Regulated intramembrane proteolysis (RIP) may provide
an explanation for the detection of a transmembrane pro-
tein like teneurin-1 in the nucleus. There is only a limited
set of known intramembrane proteases, all of which
exhibit specificity for either Type-I (presenilin, rhomboid)
or Type-II (site-2 protease, signal peptide peptidase) trans-
membrane proteins. Therefore, only the latter two are
possible candidates for teneurin processing, including the
recently identified SPP-like proteases [32]. Site-2 protease
was the first intramembrane protease discovered, releas-
ing the transcription factor SREBP from the ER-membrane
in response to sterol depletion [33]. In addition, it has
been shown to cleave ATF6, another transcription factor,
in response to ER stress [34]. The expression pattern of
SPP studied in adult mice partially overlaps with teneurin
expression in distinct brain regions [35]. No data are
available of SPP-like proteases in vertebrates, but a study
in C. elegans suggests an important role in development
[36]. Presenilin is the most studied intramembrane pro-
tease, responsible for the cleavage of Notch [37-39], APP
[40,41] and other substrates, including some cadherins
and ephrins. Most C-terminal fragments resulting from
presenilin processing exhibit signaling activity and many
of them localize to the nucleus, where they regulate tran-
scription [42]. However, since presenilin only cuts type-I
transmembrane proteins, it is not a candidate protease for
teneurin processing.
Western blot analysis showed a prominent band at about
65 kDa using the ICD-antibody, which is larger than the
predicted size of the ICD. A common feature of RIP is that
a cleavage on the extracellular side has to occur first,
resulting in the release of the ECD, before the remainderBMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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of the protein can be a substrate for intramembrane cleav-
age. Therefore, this band most likely represents teneurin-
1 after ectodomain shedding, which then, depending on
the cellular context, is further processed to result in a sol-
uble ICD (i.e., the faint smaller bands observed on the
immunoblot). This fits with the observation that the 65
kDa band is very abundant in brain lysates, but nuclear
ICD is observed in only few cells.
Based on the presence of nuclear ICD in mesenchyme as
well as in a restricted subset of neurons, we can not draw
a conclusion regarding a general biological function of
teneurin processing during development. The occurrence
of the nuclear ICD in such different cells and tissues
implies a cell-type- or tissue-specific role for teneurin-1
intracellular signalling. This was particularly striking in
the retina where we observed retinal ganglion cells nega-
tive for teneurin-1 and teneurin-1-positive cells with and
without the nuclear ICD next to each other. One example
of how to further address the biological relevance of these
observations is provided by the elegant studies of Notch
processing in genetically engineered mice. Replacement of
the Notch ICD with Cre recombinase permitted the iden-
tification of cells in which Notch is cleaved, since the
released Cre induces β-gal expression and labels specifi-
cally these cells [43].
Future work will have to be dedicated to finding the pro-
teases responsible for teneurin processing and the elucida-
tion of the function of the teneurin-1 ICD in the nucleus.
Since this cleavage occurs only in subsets of cells at spe-
cific time points during development, it will be interesting
to know if homophilic interactions or interactions with a
yet to be identified ligand triggers the cleavage of the ICD.
Conclusion
In this study we show that teneurin-1 is expressed in inter-
connected regions of the developing chick brain, and its
expression pattern is complementary to teneurin-2. We
present the first evidence of teneurin processing in verte-
brates and demonstrate that the ICD of teneurin-1 con-
tains a functional NLS. Our results provide support for the
hypothesis that teneurins can be proteolytically processed
to generate a soluble ICD that translocates to the nucleus
(Fig. 6).
Methods
In situ hybridization
Chicken embryos were sacrificed at different developmen-
tal stages and fixed in cold 4% paraformaldehyde in phos-
phate buffered saline (PBS) for a few hours or overnight,
depending on the age. For E17, brain and eyes were dis-
sected out, otherwise whole embryos or heads were used.
Tissues were cryoprotected in 25% sucrose overnight
before embedding in OCT Tissue-Tek (Sakura). Horizon-
tal, sagittal and transversal sections were cut on a Microm
cryostat, mounted on Superfrost slides (Menzel-Gläser),
dried and stored at -80°C. The probe was synthesized by
in vitro transcription of a chicken teneurin-1 EcoRI-XbaI
fragment corresponding to 628 bp within the ICD cloned
into pSPT18 using the Roche DIG RNA labeling kit. In situ
hybridization was performed on a Ventana automatic
staining module and the Ventana RiboMap and BlueMap
kits. The in situ hybridization protocol included prefixa-
tion, cell conditioning and protease pretreatment. Probe
was allowed to hybridize for 6 h at 65°C followed by
three washes with increasing stringency (1 × SSC, 0.5 ×
SSC and 0.1 × SSC at 65°C, respectively). After post-fixa-
tion, the probe was detected with anti-DIG (Roche) for 32
min and the slides were incubated with AP-substrate for 6
h. Antisense and sense controls were always performed in
parallel.
Immunohistochemistry
Cryosections of chicken embryos at various embryonic
stages were prepared as outlined above. Sections were
hydrated in PBS, blocked with 0.5% BSA and incubated
overnight in appropriately diluted primary antibody. Pri-
mary antibodies included rabbit polyclonal antisera
raised against recombinant proteins corresponding to: 1)
the 160 N-terminal amino acids of the ICD of chicken ten-
eurin-1 (anti-ICD, [21]; the 300 C-terminal amino acids
of the extracellular domain of chicken teneurin-1 (anti-
ECD, [21]; 3) a fusion of the N-terminus of tenascin-C
(for protein purification purposes) and the 8 EGF-like
domains of chicken teneurin-1 (anti-EGF; see Fig. 3A for a
summary of the teneurin-1 antisera). The latter antiserum
was preabsorbed against purified tenascin-C prior to use
to eliminate background. A previously described antise-
rum to chicken teneurin-2 [8] and a commercially availa-
ble neuronal marker (the mouse monoclonal antibody
TuJ1; Sigma) were also used. After incubation overnight in
primary antibody the sections were rinsed in PBS, blocked
again in PBS/BSA, and incubated for 2 hr in Alexa-tagged
anti-rabbit or anti-mouse secondary antibodies (Invitro-
gen). For controls, adjacent sections were incubated in
either diluted preimmune serum, with secondary anti-
body alone or the primary antibody blocked with the anti-
gen peptide. In all cases the control sections were
unstained. Sections were viewed using Nikon Optiphot
and a Zeiss Axiophot photomicroscopes with epi-illumi-
nation.
Cloning of constructs, cell culture and transfection
The teneurin-1 ICD missing the NLS was produced by
two-step PCR from pCEP-ten1 ICD. Primers containing
codons for alanines instead of arginines and lysines were
used to introduce the mutation. The second PCR product
was cloned into pCEP using NotI and XbaI. Primers used
for mutagenesis were pCEP fw:BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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5'AGAGCTCGTTTAGTGAACCT3', Ten1 NLS fw:
5'TACAACAGTCAAAGCGCGGCGGCGGCGAATACTGA
CCAATCC3', Ten1 NLS rev:
5'GGATTGGTCAGTATTCGCCGCCGCCGCGCTTTGACT
GTTGTA3' and EBV rev: 5'GTGGTTTGTCCAAACTCATC3'.
To generate a fusion protein containing the tenascin-C N-
terminus for secretion and the teneurin-1 EGF-like repeats
for antibody-generation, two step PCR was performed
using the following primers: KS:5'
CGAGGTCGACGGTATCG3', TNC/EGF fw
5'AAAGGCCCCACCTGCTCCTTGTTTGGTTTAACCTGG3'
, TNC/EGF rev:
5'CCAGGTTAAACCAAACAAGGAGCAGTTGGGGCCTTT
3' and EGF-His-Xho-rev:
5'ACTACTCGAGTTAGTGGTGGTGGTGGTGGTGCATTTC
CATGACAACGTT3'. The PCR fragment was cloned using
HindIII and XhoI into pCEP. This recombinant protein
was expressed in 293T EBNA-cells and purified using the
C-terminal HIS-tag to immunize rabbits. To remove
tenascin-C immunoreactivity of the resulting antiserum, it
was purified on a tenascin-C column.
Model of teneurin signalling Figure 6
Model of teneurin signalling. This model describes how an intracellular domain (ICD) could be generated from a trans-
membrane protein and transported to the nucleus. This process takes place only in specific cells and tissues where the anti-
ICD labeled nuclei. 1) A first protease sheds the extracellular domain (ECD) of teneurins. 2) The remainder of teneurin-1 can 
now become a substrate for an intramembrane protease. 3) The ICD is released. 4) The soluble ICD translocates to the 
nucleus via nuclear localization signal (NLS). EGF, EGF-like repeats; YD, YD-repeats. Red arrows indicate postulated cleavage sites and 
the yellow spheres proteins interacting with teneurin-1 ICD in the nucleus.BMC Developmental Biology 2008, 8:30 http://www.biomedcentral.com/1471-213X/8/30
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COS-7 cells were maintained in DMEM containing 10%
FCS. For transfection, the FUGENE reagent (Roche) was
used according to the manufacturer's protocol. The cells
were harvested 24 h after transfection for analysis.
Immunocytochemistry following transfection
24 h after transfection, the cells were fixed for 10 min with
4% paraformaldehyde, permeabilized with 1% Triton-X,
blocked with BSA for 15 min, and stained with anti-ICD
(1:300) or anti-Flag (1:1000). Secondary antibodies cou-
pled with FITC from Alexa were used, and the nuclei were
counterstained with Hoechst dye. Images were acquired
on a Z1 fluorescence microscope. The 40× objective was
used to obtain images showing the localization of the ten-
eurin-1 ICD in detail. Low-magnification pictures were
used for quantification by counting cells and classifying
them as nuclear, cytoplasmic or undetermined localiza-
tion of the ICD. The experiment was repeated three times,
capturing five random images per transfection each time.
All transfected cells on the images were counted: 492 for
the ICD- wt construct and 420 for the NLS-mut construct.
Nuclear staining was classified when the staining intensity
was higher in the nucleus than in the cytoplasm, other-
wise the cells were scored as cytoplasmic. The scoring was
performed by an independent person who was not aware
of which images were from ICD-wt or NLS-mut transfec-
tions. Cells were classified as undetermined if they were
dividing, or if the staining intensity was too bright to
determine if it is nuclear or cytoplasmic.
Western blot analysis
The specificity of the teneurin-1 and -2 antibodies was
confirmed by detection of teneurin-1 and -2 in transfected
cells. Chicken embryos at E17 were sacrificed and tissues
were dissected out and frozen in liquid nitrogen. After
grinding with a mortar and pestle, the powder was dis-
solved in RIPA buffer. Sample buffer containing β-mer-
captoethanol was added and the lysate was heated at
95°C before loading on a 4–12% gradient gel (BioRad)
for SDS-PAGE. The Benchmark prestained protein ladder
and HiMark prestained protein standards (both from Inv-
itrogen) were used to determine the size of the bands.
Transfer to an immobilon membrane was performed at
45 V per gel for 2 h. For detection, both rabbit polyclonal
antibodies anti-ICD and anti-ECD were used at a dilution
of 1:1000.
To analyze COS-7 cell lysates, culture medium was
removed and the cells were washed with PBS. For the total
lysate, cells were lysed in sample buffer containing β-mer-
captoethanol directly. The cytoplasmic and nuclear extract
was prepared using the NuCLEAR kit from Sigma follow-
ing the manufacturer's instructions. SDS-PAGE was per-
formed on 12.5% gels, and the proteins transferred for 1
h at 45 V per gel. The transfected ICD was detected with an
anti-ICD or anti-Flag antibody diluted 1:1000. Anti-vin-
culin (hvin1, Sigma, 1:1000) served as a cytoplasmic
marker and oct-1 (Santa Cruz, 1:1000) as a nuclear
marker. SuperSignal (Pierce) was used for detection of
horseradish-peroxidase coupled secondary antibody,
which was used at 1:10,000. Chemiluminescence detec-
tion films were exposed and developed, and the results
were scanned for image processing. Quantification of the
western blot was performed using ImageJ 1.33 [44]. The
intensity of the entire bands was measured, and the back-
ground was substracted. The nuclear-to-cytoplasmic
ration was calculated by dividing the nuclear intensity by
the cytoplasmic intensity, which indicates nuclear accu-
mulation of the ICD.
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